Enterovirus A71 Infection and Neurologic Disease, Madrid, Spain, 2016

• Main Authors: Carmen Niño Taravilla, Isabel Pérez-Sebastián, Alberto García Salido, Claudia Varela Serrano, Verónica Cantarín Extremera, Anna Duat Rodríguez, Laura López Marín, Mercedes Alonso Sanz, Olga María Suárez Traba, Ana Serrano González
• Format: Article
• Language: English
• Published: Centers for Disease Control and Prevention 2019-01-01
• Series: Emerging Infectious Diseases
• Subjects: Enterovirus epidemic; epidemiology; encephalitis; encephalomyelitis; viruses; Madrid
• Online Access: https://wwwnc.cdc.gov/eid/article/25/1/18-1089_article
• ISSN: 1080-6040; 1080-6059

We conducted an observational study from January 2016 through January 2017 of patients admitted to a reference pediatric hospital in Madrid, Spain, for neurologic symptoms and enterovirus infection. Among the 30 patients, the most common signs and symptoms were fever, lethargy, myoclonic jerks, and ataxia. Real-time PCR detected enterovirus in the cerebrospinal fluid of 8 patients, nasopharyngeal aspirate in 17, and anal swab samples of 5. The enterovirus was genotyped for 25 of 30 patients; enterovirus A71 was the most common serotype (21/25) and the only serotype detected in patients with brainstem encephalitis or encephalomyelitis. Treatment was intravenous immunoglobulins for 21 patients and corticosteroids for 17. Admission to the pediatric intensive care unit was required for 14 patients. All patients survived. At admission, among patients with the most severe disease, leukocytes were elevated. For children with brainstem encephalitis or encephalomyelitis, clinicians should look for enterovirus and not limit testing to cerebrospinal fluid.